BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li N, Zhan X. Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer. EPMA J 2019;10:273-90. [PMID: 31462944 DOI: 10.1007/s13167-019-00175-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 68] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Peng Y, Huang X, Wang H. lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p. BMC Mol and Cell Biol 2022;23:34. [DOI: 10.1186/s12860-022-00432-7] [Reference Citation Analysis]
2 Huang X, Zhou H, Yang X, Shi W, Hu L, Wang J, Zhang F, Shao F, Zhang M, Jiang F, Wang Y. Construction and analysis of expression profile of exosomal lncRNAs in pleural effusion in lung adenocarcinoma. Clinical Laboratory Analysis 2022. [DOI: 10.1002/jcla.24777] [Reference Citation Analysis]
3 Gao Y, Jia Z. Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma. Genetics Research 2022;2022:1-11. [DOI: 10.1155/2022/6004852] [Reference Citation Analysis]
4 Fan Y, Zhang S, Ma S. Survival Analysis with High-Dimensional Omics Data Using a Threshold Gradient Descent Regularization-Based Neural Network Approach. Genes (Basel) 2022;13:1674. [PMID: 36140842 DOI: 10.3390/genes13091674] [Reference Citation Analysis]
5 Wang J, Li T, Wei S, Zhao G, Ye C, Ma Q, Ma J, Cheng X, Zheng M. Identification of Novel Hypoxia Subtypes for Prognosis Based on Machine Learning Algorithms. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/1508113] [Reference Citation Analysis]
6 Qiao Y, Yuan F, Wang X, Hu J, Mao Y, Zhao Z. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis. Cancer Biomark 2022. [PMID: 36120772 DOI: 10.3233/CBM-220151] [Reference Citation Analysis]
7 Wang O, Shi D, Li Y, Zhou X, Yan H, Yao Q. lncRNA pair as candidate diagnostic signature for colorectal cancer based on the within-sample relative expression levels. Front Oncol 2022;12:912882. [DOI: 10.3389/fonc.2022.912882] [Reference Citation Analysis]
8 Yang M, Zheng H, Xu K, Yuan Q, Aihaiti Y, Cai Y, Xu P. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA. Front Immunol 2022;13:919231. [DOI: 10.3389/fimmu.2022.919231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fan W, Chen X, Li R, Zheng R, Wang Y, Guo Y. A prognostic risk model for ovarian cancer based on gene expression profiles from gene expression omnibus database. Biochem Genet 2022. [PMID: 35761155 DOI: 10.1007/s10528-022-10232-5] [Reference Citation Analysis]
10 Ji Y, Zhang G, Zhang X. Identification of LncRNA CARD8-AS1 as a Potential Prognostic Biomarker Associated With Progression of Lung Adenocarcinoma. Br J Biomed Sci 2022;79:10498. [DOI: 10.3389/bjbs.2022.10498] [Reference Citation Analysis]
11 Zhao N, Guo M, Zhang C, Wang C, Wang K. Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers. Front Cell Dev Biol 2022;10:882698. [PMID: 35721492 DOI: 10.3389/fcell.2022.882698] [Reference Citation Analysis]
12 Chen Y, Guo Y, Li S, Xu J, Wang X, Ning W, Ma L, Qu Y, Zhang M, Zhang H. Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma. Front Oncol 2022;12:789283. [PMID: 35311131 DOI: 10.3389/fonc.2022.789283] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Sun GK, Xu ZJ, Nan FY, Tang LJ, Yao DM. Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemia. Int J Lab Hematol 2022. [PMID: 35218157 DOI: 10.1111/ijlh.13809] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Meng K, Hu X, Zheng G, Qian C, Xin Y, Guo H, He R, Ge M, Xu J. Identification of prognostic biomarkers for papillary thyroid carcinoma by a weighted gene co‐expression network analysis. Cancer Medicine. [DOI: 10.1002/cam4.4602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cheng H, Bian C, Chu Y, Mei J, Xie J. Effects of Dual-Frequency Ultrasound-Assisted Thawing Technology on Thawing Rate, Quality Properties, and Microstructure of Large Yellow Croaker (Pseudosciaena crocea). Foods 2022;11:226. [DOI: 10.3390/foods11020226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Liu X, Zhang X, Du S. Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2. Cell Cycle 2022;:1-11. [PMID: 34985374 DOI: 10.1080/15384101.2021.2020433] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Gu P, Zhang L, Wang R, Ding W, Wang W, Liu Y, Wang W, Li Z, Yan B, Sun X. Development and Validation of a Novel Hypoxia-Related Long Noncoding RNA Model With Regard to Prognosis and Immune Features in Breast Cancer. Front Cell Dev Biol 2021;9:796729. [PMID: 34977036 DOI: 10.3389/fcell.2021.796729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Liu Q, Zhang H, Yang X, Liu X, Yin F, Guo P, Yin Y, Zheng K, Yang Z, Han Y. Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer. Ann Transl Med 2022;10:126. [PMID: 35282039 DOI: 10.21037/atm-21-6422] [Reference Citation Analysis]
19 Chen H, Hu Z, Sang M, Ni S, Lin Y, Wu C, Mu Y, Liu K, Wu S, Li N, Xu G. Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma. Front Genet 2021;12:767694. [PMID: 34956321 DOI: 10.3389/fgene.2021.767694] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Zhou Z, Bai J, Zhong S, Zhang R, Kang K, Zhang X, Xu Y, Zhao C, Zhao M. Integrative genomic analysis of PPP3R1 in Alzheimer's disease: a potential biomarker for predictive, preventive, and personalized medical approach. EPMA J 2021;12:647-58. [PMID: 34956428 DOI: 10.1007/s13167-021-00261-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Nomiri S, Karami H, Baradaran B, Javadrashid D, Derakhshani A, Nourbakhsh NS, Shadbad MA, Solimando AG, Tabrizi NJ, Brunetti O, Nasseri S, Racanelli V, Safarpour H, Silvestris N. Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis. Biomed Pharmacother 2021;146:112537. [PMID: 34922114 DOI: 10.1016/j.biopha.2021.112537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Yang CZ, Hu LH, Huang ZY, Deng L, Guo W, Liu S, Xiao X, Yang HX, Lin JT, Sun LL, Lin LZ. Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer. PLoS One 2021;16:e0260720. [PMID: 34855841 DOI: 10.1371/journal.pone.0260720] [Reference Citation Analysis]
23 Wu W, Gao C, Chen L, Zhang D, Guo S. Comprehensive analysis of competitive endogenous RNAs networks reveals potential prognostic biomarkers associated with epithelial ovarian cancer. Oncol Lett 2021;22:843. [PMID: 34777587 DOI: 10.3892/ol.2021.13104] [Reference Citation Analysis]
24 Huang Y, Li X, Chen W, He Y, Wu S, Li X, Hou B, Wang S, He Y, Jiang H, Lun Y, Zhang J. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma. Int Immunopharmacol 2021;101:108286. [PMID: 34735975 DOI: 10.1016/j.intimp.2021.108286] [Reference Citation Analysis]
25 Zhang Y, Mao Q, Xia Q, Cheng J, Huang Z, Li Y, Chen P, Yang J, Fan X, Liang Y, Lin H. Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers. J Hematol Oncol 2021;14:169. [PMID: 34654454 DOI: 10.1186/s13045-021-01179-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
26 Guo Y, Sun P, Guo W, Dong Z. Long Non-coding RNA LINC01503 Promotes Gastric Cardia Adenocarcinoma Progression via miR-133a-5p/VIM Axis and EMT Process. Dig Dis Sci 2021;66:3391-403. [PMID: 33200343 DOI: 10.1007/s10620-020-06690-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Wen A, Luo L, Du C, Luo X. Long non-coding RNA miR155HG silencing restrains ovarian cancer progression by targeting the microRNA-155-5p/tyrosinase-related protein 1 axis. Exp Ther Med 2021;22:1237. [PMID: 34539833 DOI: 10.3892/etm.2021.10672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wang W, Min K, Chen G, Zhang H, Deng J, Lv M, Cao Z, Zhou Y. Use of bioinformatic database analysis and specimen verification to identify novel biomarkers predicting gastric cancer metastasis. J Cancer 2021;12:5967-76. [PMID: 34476011 DOI: 10.7150/jca.58768] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 Zhao Y, Liu L, Zhao J, Du X, Yu Q, Wu J, Wang B, Ou R. Construction and Verification of a Hypoxia-Related 4-lncRNA Model for Prediction of Breast Cancer. Int J Gen Med 2021;14:4605-17. [PMID: 34429643 DOI: 10.2147/IJGM.S322007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
30 Li Y, Zhai Y, Chen Y. GATA1-induced upregulation of LINC01503 promotes carboplatin resistance in ovarian carcinoma by upregulating PD-L1 via sponging miR-766-5p. J Ovarian Res 2021;14:108. [PMID: 34425872 DOI: 10.1186/s13048-021-00856-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Rothzerg E, Ho XD, Xu J, Wood D, Märtson A, Kõks S. Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma. Genes (Basel) 2021;12:1132. [PMID: 34440306 DOI: 10.3390/genes12081132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
32 Li F, Yang BB. Non-Coding RNAs in Invadopodia: New Insights Into Cancer Metastasis. Front Oncol 2021;11:681576. [PMID: 34290983 DOI: 10.3389/fonc.2021.681576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Lin F, Zhang H, Bao J, Li L. Identification of Potential Diagnostic miRNAs Biomarkers for Alzheimer Disease Based on Weighted Gene Coexpression Network Analysis. World Neurosurg 2021;153:e315-28. [PMID: 34224891 DOI: 10.1016/j.wneu.2021.06.118] [Reference Citation Analysis]
34 Zheng J, Guo J, Zhang H, Cao B, Xu G, Zhang Z, Tong J. Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer. Front Genet 2021;12:672674. [PMID: 34367239 DOI: 10.3389/fgene.2021.672674] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
35 Wang S, Song Z, Tan B, Zhang J, Zhang J, Liu S. Identification and Validation of Hub Genes Associated With Hepatocellular Carcinoma Via Integrated Bioinformatics Analysis. Front Oncol 2021;11:614531. [PMID: 34277395 DOI: 10.3389/fonc.2021.614531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
36 Song HK, Kim SY. The Role of Sex-specific Long Non-coding RNAs in Cancer Prevention and Therapy. J Cancer Prev 2021;26:98-109. [PMID: 34258248 DOI: 10.15430/JCP.2021.26.2.98] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Wang J, Hao JP, Uddin MN, Wu Y, Chen R, Li DF, Xiong DQ, Ding N, Yang JH, Ding XS. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia. Aging (Albany NY) 2021;13:16445-70. [PMID: 34148032 DOI: 10.18632/aging.203166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
38 Zhu L, Cui K, Weng L, Yu P, Du Y, Zhang T, Liu H, Li B, Ma W. A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells. PLoS One 2021;16:e0249174. [PMID: 34086679 DOI: 10.1371/journal.pone.0249174] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
39 Wang Y, Gao WJ. Long non-coding RNA-H19 promotes ovarian cancer cell proliferation and migration via the microRNA-140/Wnt1 axis. Kaohsiung J Med Sci 2021;37:768-75. [PMID: 34002485 DOI: 10.1002/kjm2.12393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Hou P, Lin T, Meng S, Shi M, Chen F, Jiang T, Li Z, Li M, Chu S, Zheng J, Bai J. Long noncoding RNA SH3PXD2A-AS1 promotes colorectal cancer progression by regulating p53-mediated gene transcription. Int J Biol Sci 2021;17:1979-94. [PMID: 34131400 DOI: 10.7150/ijbs.58422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ștefan PA, Lupean RA, Mihu CM, Lebovici A, Oancea MD, Hîțu L, Duma D, Csutak C. Ultrasonography in the Diagnosis of Adnexal Lesions: The Role of Texture Analysis. Diagnostics (Basel) 2021;11:812. [PMID: 33947150 DOI: 10.3390/diagnostics11050812] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
42 Levit SL, Tang C. Polymeric Nanoparticle Delivery of Combination Therapy with Synergistic Effects in Ovarian Cancer. Nanomaterials (Basel) 2021;11:1048. [PMID: 33923947 DOI: 10.3390/nano11041048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
43 Lee H, Kwon OB, Lee JE, Jeon YH, Lee DS, Min SH, Kim JW. Repositioning Trimebutine Maleate as a Cancer Treatment Targeting Ovarian Cancer Stem Cells. Cells 2021;10:918. [PMID: 33923707 DOI: 10.3390/cells10040918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Pan Q, Huang Y, Wang Y, Li D, Lei C. LncRNA ACTA2-AS1 suppress colon adenocarcinoma progression by sponging miR-4428 upregulation BCL2L11. Cancer Cell Int 2021;21:203. [PMID: 33845844 DOI: 10.1186/s12935-021-01769-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
45 Atallah GA, Abd Aziz NH, Teik CK, Shafiee MN, Kampan NC. New Predictive Biomarkers for Ovarian Cancer. Diagnostics (Basel) 2021;11:465. [PMID: 33800113 DOI: 10.3390/diagnostics11030465] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
46 Liang H, Bai Y, Wang H, Yang X. Identification of LncRNA Prognostic Markers for Ovarian Cancer by Integration of Co-expression and CeRNA Network. Front Genet 2020;11:566497. [PMID: 33664764 DOI: 10.3389/fgene.2020.566497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
47 Han Y, Yu X, Yin Y, Lv Z, Jia C, Liao Y, Sun H, Liu T, Cong L, Fei Z, Fu D, Cong X, Qu S. Identification of Potential BRAF Inhibitor Joint Therapy Targets in PTC based on WGCAN and DCGA. J Cancer 2021;12:1779-91. [PMID: 33613767 DOI: 10.7150/jca.51551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
48 Ye Z, Zheng M, Zeng Y, Wei S, Wang Y, Lin Z, Shu C, Xie Y, Zheng Q, Chen L. Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma. Front Genet 2020;11:595477. [PMID: 33362856 DOI: 10.3389/fgene.2020.595477] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
49 Li N, Li H, Wang Y, Cao L, Zhan X. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine. EPMA J 2020;11:661-94. [PMID: 33240452 DOI: 10.1007/s13167-020-00224-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
50 Zou Y, Chen B. Long non-coding RNA HCP5 in cancer. Clin Chim Acta 2021;512:33-9. [PMID: 33245911 DOI: 10.1016/j.cca.2020.11.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
51 Ma W, Zhao F, Yu X, Guan S, Suo H, Tao Z, Qiu Y, Wu Y, Cao Y, Jin F. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature. J Transl Med 2020;18:442. [PMID: 33225954 DOI: 10.1186/s12967-020-02522-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 20.0] [Reference Citation Analysis]
52 Gu H, Tu H, Liu L, Liu T, Liu Z, Zhang W, Liu J. RSPO3 is a marker candidate for predicting tumor aggressiveness in ovarian cancer. Ann Transl Med 2020;8:1351. [PMID: 33313096 DOI: 10.21037/atm-20-3731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
53 Guo S, Zhu KX, Yu WH, Wang T, Li S, Wang YX, Zhang CC, Guo JQ. SH3PXD2A-AS1/miR-330-5p/UBA2 ceRNA network mediates the progression of colorectal cancer through regulating the activity of the Wnt/β-catenin signaling pathway. Environ Toxicol 2021;36:1969-80. [PMID: 33073888 DOI: 10.1002/tox.23038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
54 Lupean RA, Ștefan PA, Feier DS, Csutak C, Ganeshan B, Lebovici A, Petresc B, Mihu CM. Radiomic Analysis of MRI Images is Instrumental to the Stratification of Ovarian Cysts. J Pers Med 2020;10:E127. [PMID: 32937851 DOI: 10.3390/jpm10030127] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
55 Luo Q, Wang S, Han H, Xie F, Chen J. High expression of the long noncoding RNA SH3PXD2A-AS1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma. J Int Med Res 2020;48:030006052094905. [DOI: 10.1177/0300060520949059] [Reference Citation Analysis]
56 Zhang J, Huang J, Chen W, Hu Z, Wang X. miR-143-3p Targets lncRNA PSMG3-AS1 to Inhibit the Proliferation of Hepatocellular Carcinoma Cells. Cancer Manag Res 2020;12:6303-9. [PMID: 32801875 DOI: 10.2147/CMAR.S242179] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
57 Kong S, Xue H, Li Y, Li P, Ma F, Liu M, Li W. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p. Exp Cell Res 2020;395:112180. [PMID: 32682012 DOI: 10.1016/j.yexcr.2020.112180] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
58 Wang L, He M, Fu L, Jin Y. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells. Exp Cell Res 2020;394:112129. [PMID: 32511950 DOI: 10.1016/j.yexcr.2020.112129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
59 Li N, Zhan X. Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes. EPMA J 2020;11:289-309. [PMID: 32549918 DOI: 10.1007/s13167-020-00209-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
60 Zhou Y, Fu X, Zheng Z, Ren Y, Zheng Z, Zhang B, Yuan M, Duan J, Li M, Hong T, Lu G, Zhou D. Identification of gene co-expression modules and hub genes associated with the invasiveness of pituitary adenoma. Endocrine 2020;68:377-89. [PMID: 32342269 DOI: 10.1007/s12020-020-02316-2] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Li D, Chai L, Yu X, Song Y, Zhu X, Fan S, Jiang W, Qiao T, Tong J, Liu S, Fan L, Lv Z. The HOTAIRM1/miR-107/TDG axis regulates papillary thyroid cancer cell proliferation and invasion. Cell Death Dis 2020;11:227. [PMID: 32269214 DOI: 10.1038/s41419-020-2416-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
62 Lee H, Kim JW, Kim DK, Choi DK, Lee S, Yu JH, Kwon OB, Lee J, Lee DS, Kim JH, Min SH. Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells. Int J Mol Sci 2020;21:E2327. [PMID: 32230901 DOI: 10.3390/ijms21072327] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
63 Wu M, Sun Y, Wu J, Liu G. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis. Med Sci Monit 2020;26:e922107. [PMID: 32180586 DOI: 10.12659/MSM.922107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
64 Li N, Zhan X. MASS SPECTROMETRY‐BASED MITOCHONDRIAL PROTEOMICS IN HUMAN OVARIAN CANCERS. Mass Spec Rev 2020;39:471-98. [DOI: 10.1002/mas.21618] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
65 Yuan D, Qian H, Guo T, Ye J, Jin C, Liu X, Jiang L, Wang X, Lin M, Yu H. LncRNA-ATB Promotes the Tumorigenesis of Ovarian Cancer via Targeting miR-204-3p. Onco Targets Ther 2020;13:573-83. [PMID: 32021299 DOI: 10.2147/OTT.S230552] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
66 Liu H, Chen R, Kang F, Lai H, Wang Y. KCNQ1OT1 promotes ovarian cancer progression via modulating MIR-142-5p/CAPN10 axis. Mol Genet Genomic Med 2020;8:e1077. [PMID: 31909901 DOI: 10.1002/mgg3.1077] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
67 Bao M, Shi R, Zhang K, Zhao Y, Wang Y, Bao X. Development of a membrane lipid metabolism-based signature to predict overall survival for personalized medicine in ccRCC patients. EPMA J 2019;10:383-93. [PMID: 31832113 DOI: 10.1007/s13167-019-00189-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]